Ge Hao , Changming Xiong , Jie Xiao , Wei He , Yuhua Zhu , Liwen Xu , Qing Jiang , Guangyou Yang
{"title":"Evaluation of the immunoprotective effect of the recombinant Eimeria intestinalis rhoptry protein 25 and rhoptry protein 30 on New Zealand rabbits","authors":"Ge Hao , Changming Xiong , Jie Xiao , Wei He , Yuhua Zhu , Liwen Xu , Qing Jiang , Guangyou Yang","doi":"10.1016/j.exppara.2024.108719","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Rabbit coccidiosis is a parasitism caused by either one or multiple co-infections of <em>Eimeria</em> species. Among them, <em>Eimeria intestinalis</em> is the primary pathogen responsible for diarrhea, growth retardation, and potential mortality in rabbits. Concerns regarding drug resistance and drug residues have led to the development of recombinant subunit vaccines targeting <em>Eimeria</em> species as a promising preventive measure. The aim of this study was to assess the immunoprotective efficacy of recombinant subunit vaccines comprising <em>Ei</em>ROP25 and <em>Ei</em>ROP30 (rhoptry proteins (ROPs)) against <em>E. intestinalis</em> infection in rabbits.</p></div><div><h3>Methods</h3><p>Cloning, prokaryotic expression, and protein purification were performed to obtain <em>Ei</em>ROP25 and <em>Ei</em>ROP30. Five groups of fifty 35-day-old <em>Eimeria</em>-free rabbits were created (unchallenged control group, challenged control group, vector protein control group, r<em>Ei</em>ROP25 group, and r<em>Ei</em>ROP30 group), with 10 rabbits in each group. Rabbits in the r<em>Ei</em>ROP25 and r<em>Ei</em>ROP30 groups were immunized with the recombinant proteins (100 μg per rabbit) for primary and booster immunization (100 μg per rabbit) at a two-week intervals, and challenged with 7 × 10<sup>4</sup> oocysts per rabbit after an additional two-week interval. Two weeks after the challenge, the rabbits were euthanized for analysis. Weekly collections of rabbit sera were made to measure changes in specific IgG and cytokine level. Clinical symptoms and pathological changes after challenge were observed and recorded. At the conclusion of the animal experiment, lesion scores, the relative weight increase ratio, the oocyst reduction rate, and the anticoccidial index were computed.</p></div><div><h3>Results</h3><p>Rabbits immunized with r<em>Ei</em>ROP25 and r<em>Ei</em>ROP30 exhibited relative weight gain ratios of 56.57% and 72.36%, respectively. Oocysts decreased by 78.14% and 84.06% for the r<em>Ei</em>ROP25 and r<em>Ei</em>ROP30 groups, respectively. The anticoccidial indexes were 140 and 155. Furthermore, there was a noticeable drop in intestinal lesions. After the primary immunization with r<em>Ei</em>ROP25 and r<em>Ei</em>ROP30, a week later, there was a notable rise in specific IgG levels, which remained elevated for two weeks following challenge (<em>P</em> < 0.05). Interleukin (IL)-2 levels increased markedly in the r<em>Ei</em>ROP25 group, whereas IL-2, interferon gamma (IFN-γ), and IL-4 levels increased substantially in the r<em>Ei</em>ROP30 group (<em>P</em> < 0.05).</p></div><div><h3>Conclusion</h3><p>Immunization of rabbits indicated that both r<em>Ei</em>ROP25 and r<em>Ei</em>ROP30 are capable of inducing an increase in specific antibody levels. r<em>Ei</em>ROP25 triggered a Th1-type immune protection response, while r<em>Ei</em>ROP30 elicited a Th1/Th2 mixed response. <em>Ei</em>ROP25 and <em>Ei</em>ROP30 can generate a moderate level of immune protection, with better efficacy observed for <em>Ei</em>ROP30. This study provides valuable insights for the promotion of recombinant subunit vaccines targeting rabbit <em>E. intestinalis</em> infection.</p></div>","PeriodicalId":12117,"journal":{"name":"Experimental parasitology","volume":null,"pages":null},"PeriodicalIF":1.4000,"publicationDate":"2024-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental parasitology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0014489424000225","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PARASITOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Rabbit coccidiosis is a parasitism caused by either one or multiple co-infections of Eimeria species. Among them, Eimeria intestinalis is the primary pathogen responsible for diarrhea, growth retardation, and potential mortality in rabbits. Concerns regarding drug resistance and drug residues have led to the development of recombinant subunit vaccines targeting Eimeria species as a promising preventive measure. The aim of this study was to assess the immunoprotective efficacy of recombinant subunit vaccines comprising EiROP25 and EiROP30 (rhoptry proteins (ROPs)) against E. intestinalis infection in rabbits.
Methods
Cloning, prokaryotic expression, and protein purification were performed to obtain EiROP25 and EiROP30. Five groups of fifty 35-day-old Eimeria-free rabbits were created (unchallenged control group, challenged control group, vector protein control group, rEiROP25 group, and rEiROP30 group), with 10 rabbits in each group. Rabbits in the rEiROP25 and rEiROP30 groups were immunized with the recombinant proteins (100 μg per rabbit) for primary and booster immunization (100 μg per rabbit) at a two-week intervals, and challenged with 7 × 104 oocysts per rabbit after an additional two-week interval. Two weeks after the challenge, the rabbits were euthanized for analysis. Weekly collections of rabbit sera were made to measure changes in specific IgG and cytokine level. Clinical symptoms and pathological changes after challenge were observed and recorded. At the conclusion of the animal experiment, lesion scores, the relative weight increase ratio, the oocyst reduction rate, and the anticoccidial index were computed.
Results
Rabbits immunized with rEiROP25 and rEiROP30 exhibited relative weight gain ratios of 56.57% and 72.36%, respectively. Oocysts decreased by 78.14% and 84.06% for the rEiROP25 and rEiROP30 groups, respectively. The anticoccidial indexes were 140 and 155. Furthermore, there was a noticeable drop in intestinal lesions. After the primary immunization with rEiROP25 and rEiROP30, a week later, there was a notable rise in specific IgG levels, which remained elevated for two weeks following challenge (P < 0.05). Interleukin (IL)-2 levels increased markedly in the rEiROP25 group, whereas IL-2, interferon gamma (IFN-γ), and IL-4 levels increased substantially in the rEiROP30 group (P < 0.05).
Conclusion
Immunization of rabbits indicated that both rEiROP25 and rEiROP30 are capable of inducing an increase in specific antibody levels. rEiROP25 triggered a Th1-type immune protection response, while rEiROP30 elicited a Th1/Th2 mixed response. EiROP25 and EiROP30 can generate a moderate level of immune protection, with better efficacy observed for EiROP30. This study provides valuable insights for the promotion of recombinant subunit vaccines targeting rabbit E. intestinalis infection.
期刊介绍:
Experimental Parasitology emphasizes modern approaches to parasitology, including molecular biology and immunology. The journal features original research papers on the physiological, metabolic, immunologic, biochemical, nutritional, and chemotherapeutic aspects of parasites and host-parasite relationships.